A modified anthrax toxin-based enzyme-linked immunospot assay reveals robust T cell responses in symptomatic and asymptomatic Ebola virus exposed individuals
Bobby Brooke Herrera(Harvard University), Phyllis J. Kanki(Harvard University), Sulaimon Akanmu(University of Lagos), Rolake Akinsola(Lagos University Teaching Hospital), Charlotte A. Chang(Harvard University), Onikepe Folarin(Redeemer's University), Folasade Ogunsola(University of Lagos), Philomena Eromon(Norwegian Womens Public Health Association), Christian Happi(Harvard University), Yichen Lu, Adeyemi T. Kayode(Norwegian Womens Public Health Association), Philip O Oshun(University of Lagos), Donald J. Hamel(Harvard University)
Cited by 16
Related Papers
Urgent need for a non-discriminatory and non-stigmatizing nomenclature for monkeypox virus
|PLoS Biology|2022|350
Lassa Fever in Post-Conflict Sierra Leone
|PLoS neglected tropical diseases|2014|236
Genomic Analysis of Lassa Virus during an Increase in Cases in Nigeria in 2018
|New England Journal of Medicine|2018|197
Capturing sequence diversity in metagenomes with comprehensive and scalable probe design
|Nature Biotechnology|2019|185